海正药业 (600267)
Zhejiang Hisun Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 119884.82
- Circulating A-Shares(W): 119818.89
- Earnings Per Share(RMB): 0.4000
- Net Assets Per Share(RMB): 7.0989
- Operating Revenue(W RMB): 792279.42
- Total Profit(W RMB): 61973.51
- **Net Profit Attributable to Parent(W RMB) **: 46092.92
- Net Profit Growth Rate(%): -10.55
- Weighted Return on Equity(%): 5.4700
- Operating Cash Flow Per Share(RMB): 1.3720
- Undistributed Profit Per Share(RMB): 2.2969
- Capital Reserve Per Share(RMB): 3.5842
2. Main Business
The main business covers:
- Production of pharmaceuticals
- Production and sales of veterinary drugs
3. Company Basic Information
- Company Name: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Listing Date: 2000-07-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
- Website: https://www.hisunpharm.com/
- Company Profile: The company was established on February 11, 1998, as a joint stock company initiated by Zhejiang Hisun Group Co., Ltd. as the main sponsor, together with seven other units including SDIC Xingye Co., Ltd. (now renamed SDIC Pharmaceutical Investment Co., Ltd.), Sanlong Investment (China) Co., Ltd., Sichuan Institute of Antibiotics Industry under the State Pharmaceutical Administration, Shanghai Pharmaceutical Industry Research Institute under the State Pharmaceutical Administration, China Pharmaceutical University, Zhejiang Pharmaceutical Industry Company (now reorganized as Zhejiang Inte Pharmaceutical Co., Ltd.), and the Second Military Medical University Zhaohui Pharmaceutical Factory (now restructured and reorganized as Shanghai Fosun Zhaohui Pharmaceutical Co., Ltd.). At the time of establishment, the company's total share capital was 116 million shares, with the main sponsor contributing net assets converted into 86.6716 million shares; the other sponsors contributed net assets or cash, totaling 29.3284 million shares. After the public issuance of 40 million RMB ordinary shares, the company's total share capital reached 156 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Hisun Group Co., Ltd. | General Legal Person | 32078.36 | 26.77 |
| 2 | Zhejiang International Trade Group Co., Ltd. | General Legal Person | 7267.39 | 6.07 |
| 3 | Taizhou Jiaojiang State-owned Capital Operation Group Co., Ltd. | General Legal Person | 5993.15 | 5.00 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2865.04 | 2.39 |
| 5 | Southern China Securities 1000 ETF | Fund | 767.54 | 0.64 |
| 6 | Guotai Haitong China Securities 1000 Index Enhanced Securities Investment Fund Class A | Fund | 137.23 | 0.11 |
| 7 | Morgan Stanley Youyue Anhe Mixed Securities Investment Fund Class A | Fund | 33.32 | 0.03 |
| 8 | Hengyue Medical Health Selection Mixed Securities Investment Fund Class A | Fund | 16.44 | 0.01 |
| 9 | Guotai Xinli One Year Holding Period Mixed Securities Investment Fund Class A | Fund | 4.81 | 0.00 |
| 10 | Guotai Tongli 9 Month Holding Period Mixed Securities Investment Fund Class A | Fund | 3.63 | 0.00 |
5. Concept Sectors
- Generic Drugs
- Innovative Drugs
- Weight Loss Drugs
- Synthetic Biology
- Pet Economy
- DeepSeek
- Margin Trading
- Share Repurchase Plan
- Free Cash Flow
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information